Pancreatic cancer in cystic fibrosis after bilateral lung transplantation

Pancreas

Volumn 33, Issue 4, 2006, Pages 430-432

  Petrowsky, Henrik ^a   Schuster, Horst ^a   Irani, Sarosh ^a   Schäfer, Markus ^a   Jochum, Wolfram ^a   Schmid, Christoph ^a   Boehler, Annette ^a   Clavien, Pierre Alain ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cystic fibrosis; Growth hormone treatment; Immunosuppression; Lung transplantation; Pancreatic adenocarcinoma; Pancreatic cancer

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSPORIN A; HUMAN GROWTH HORMONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ANAMNESIS; ARTICLE; CANCER RISK; CANCER SURVIVAL; CASE REPORT; CHOLANGIOGRAPHY; CHOLESTASIS; CYSTIC FIBROSIS; FEMALE; GROWTH RETARDATION; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LUNG INFECTION; LUNG TRANSPLANTATION; PANCREAS CANCER; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADENOCARCINOMA; ADOLESCENT; CHOLANGIOGRAPHY; CYSTIC FIBROSIS; FATAL OUTCOME; FEMALE; HUMAN GROWTH HORMONE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; PANCREAS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RECOMBINANT PROTEINS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750631553     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000236724.49543.f3     Document Type: Article

References (20)

1. Boat TF, Cheng PW. Epithelial cell dysfunction in cystic fibrosis: implications for airways disease. Acta Paediatr Scand Suppl. 1989;363:25.
2. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245(4922):1066.
3. Cystic fibrosis foundation. Patient registry annual data report 2003. (http://www.cff.org/publications/, accessed 2005).
4. Liou TG, Adler FR, Cahill BC, et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA. 2001;286(21):2683.
5. Sheldon CD, Hodson ME, Carpenter LM, Swerdlow AJ. A cohort study of cystic fibrosis and malignancy. Br J Cancer. 1993;68(5):1025.
6. Tsongalis GJ, Faber G, Dalldorf FG, et al. Association of pancreatic adenocarcinoma, mild lung disease, and delta F508 mutation in a cystic fibrosis patient. Clin Chem. 1994;40(10):1972.
7. Davis TM, Sawicka EH. Adenocarcinoma in cystic fibrosis. Thorax. 1985;40(3):199.
8. McIntosh JC, Schoumacher RA, Tiller RE. Pancreatic adenocarcinoma in a patient with cystic fibrosis. Am J Med. 1988;85(4):592.
9. Tedesco FJ, Brown R, Schuman BM. Pancreatic carcinoma in a patient with cystic fibrosis. Gastrointest Endosc. 1986;32(1):25.
10. Neglia JP, FitzSimmons SC, Maisonneuve P, et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med. 1995;332(8):494.
11. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999;80(6):827.
12. Ahmed N, Corey M, Forstner G, et al. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut. 2003;52(8):1159.
13. Durno C, Corey M, Zielenski J, et al. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology. 2002;123(6):1857.
14. Penn I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg. 1996;2(1):52.
15. Penn I. Primary malignancies of the hepato-biliary-pancreatic system in organ allograft recipients. J Hepatobiliary Pancreat Surg. 1998;5(2):157.
16. Ibrahim YH, Yee D. Insulin-like growth factor-I and cancer risk. Growth Horm IGF Res. 2004;14(4):261.
17. Liu JP, Baker J, Perkins AS, et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 1993;75(1):59.
18. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000;92(18):1472.
19. Howell SJ, Wilton P, Lindberg A, et al. Growth hormone replacement and the risk of malignancy in children with neurofibromatosis. J Pediatr. 1998;133(2):201.
20. Mehls O, Wilton P, Lilien M, et al. Does growth hormone treatment affect the risk of post-transplant renal cancer? Pediatr Nephrol. 2002;17(12):984.